SEC Form 4 · accession 0001631248-16-000006
Spark Therapeutics, Inc. · ONCE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Katherine A High
Officer — See Remarks · Director
Period of report
Jan 5, 2016
Accepted (ET)
Jan 7, 2016 · 5:53 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001609351
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $40.44 | Jan 5, 2016 | A | 55,000 | A | — | Jan 4, 2026 | Common Stock | 55,000 | 55,000 | D |
Explanation of responses
- F125% vests January 5, 2017 and the remainder vests in equal quarterly installments over the following three years.
Remarks
President and Chief Scientific Officer